Records containing: Raynaud Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-08Metabolomic Analysis of Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2025-07-15Potential Benefit for Non Invasive Vagus Nerve Stimulation (nVNS) Using GammaCore in the Treatment of Raynaud's Phenomena.
-
CLINICAL_TRIALS study record update · 2025-05-25DermaFlow Alpha - Multi-modal Quantitative Imaging of the Skin
-
CLINICAL_TRIALS study record update · 2024-05-21Chemical Sympathectomy Following Peripheral Nerve Block With Liposomal Bupivacaine
-
CLINICAL_TRIALS study record update · 2023-01-06Phototherapy For Treatment Of Raynaud's Phenomenon
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-11-10ClinicalTrials.gov study NCT02642146
-
CLINICAL_TRIALS study record update · 2020-11-09Effectiveness of an Intervention Program With Electric Stimulation Therapy in Patients With Raynaud's Phenomenon: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2019-02-28RaynAUT - Thermography and the Autonomic Nervous System in Raynaud's Phenomenon - Investigation of the Autonomic Nervous System in Patients With Raynaud's Phenomenon, Glaucoma, and Autonomic Neuropathy.
-
CLINICAL_TRIALS study record update · 2018-08-08A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
-
CLINICAL_TRIALS study record update · 2017-05-22Efficacy and Tolerability of Ginkgo Biloba Extract EGb 761® in Patients With Raynaud´s Phenomenon
-
CLINICAL_TRIALS study record update · 2017-01-23"Color Doppler Ultrasound Comparison of Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud: A Randomized, Double-blind, Placebo-controlled Pilot Study"
-
CLINICAL_TRIALS study record update · 2016-06-02Laser SPEckle Contrast Imaging Interest in dEtection of Cutaneous Microvascular Dysfunction in Systemic Sclerosis.
-
CLINICAL_TRIALS study record update · 2015-12-09Rôle Des Acides Epoxy-eicosatriénoïques et du Monoxyde d'Azote Dans l'hyperhémie Post-occlusive cutanée Digitale et la réponse cutanée au Froid Dans le phénomène de Raynaud Primaire
-
CLINICAL_TRIALS study record update · 2014-06-16Single Dose, Double-blind, Placebo-controlled, Single Center, Randomized Cross-over Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetic Properties of BAY63-2521 After Oral Dosing in 20 Patients With Raynaud's Phenomenon (RP)
-
CLINICAL_TRIALS study record update · 2013-03-22Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
-
CLINICAL_TRIALS study record update · 2010-07-20A Study of a Topical Formulation of Nitroglycerin, Vascana® (MQX-503), and Matching Vehicle in the Treatment and Prevention of Symptoms Associated With Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2007-05-30Phase III Laboratory Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud's Phenomenon